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Abstract: Blood banking systems in the United States over the past decade have been
faced with a volatile demand for blood, specifically, a decrease in demand for red blood cells,
for a variety of reasons. This change in the blood supply chain landscape, accompanied
by an increasing emphasis on cost efficiency, is a driver of Mergers & Acquisitions between
blood banks. In this paper, we first present supply chain network optimization pre- and
post-merger models. The models handle perishability of the life-saving product of blood,
include both operational and discarding costs of waste, capture the uncertainty associated
with the demand points, as well as the expected total blood supply shortage cost and the
total discarding cost at demand points. They also incorporate capacities on the links. Their
solution yields the optimal path and link flows plus the frequencies of activities associated
1
with blood collection, shipment, testing and processing, storage, and distribution, and in-
curred total costs. We provide a cost efficiency (synergy) measure associated with a merger
or acquisition in the blood banking industry, as well as measures capturing the expected
supply shortage and surplus. The methodological framework and its applicability are then
illustrated via a large-scale blood supply chain network example inspired by a pending merger
in the real-world in both status quo and disaster scenarios.
Keywords: blood banking, supply chains, mergers and acquisitions, efficiency measures,
perishable product
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1. Introduction
Blood services in the United States, a vital part of the healthcare system, are at a
crossroads with American blood suppliers experiencing a volatile environment over the past
decade. Prior to 2008, blood shortages were consistently reported every year by hospitals
and other medical centers resulting in the cancellation and postponement of elective surg-
eries. The scenario has since dramatically changed, placing increased pressure on this unique
industry in which the product must be donated and cannot be manufactured.
According to Whitaker (2011), the number of units of whole blood (WB) and red blood
cells (RBC) transfused in 2011 decreased by a statistically significant 8.2% from 2008, with
the percentage of decline for the units collected over that period being 9.1%. This downward
trend has continued with both numbers suffering 4.4% and 9.4% further declines over the
2011 to 2013 period, respectively (cf. Chung et al. (2016)). The demand for blood continues
to drop despite population growth and ever-increasing numbers of senior citizens. This
declining trend in blood collection and utilization is raising concerns for disaster preparedness
and other unexpected utilization needs (Chung et al. (2016)).
Researchers note that there is not a single factor for the declining utilization of most blood
products; rather, a variety of economic factors as well as medical/technological advance-
ments have contributed to the trend. Reduced hospital census due to hospital consolidations
(America’s Blood Centers (2015)) and historically low occupancy rates at hospitals (down
to 60% in 2013 from 64% five years earlier and 77% in 1980) have significantly lowered the
demand for blood (Evans (2015)). Furthermore, a lower number of elective surgeries allowed
by private insurers has resulted in a reduced need for blood transfusions (Wald (2014)). The
implementation of more conservative Patient Blood Management (PBM) initiatives as well
as a number of improvements in clinical practices are also a major cause of this declining
trend (Chung et al. (2016)).
Figure 1 from Chung et. al (2016) depicts the estimated rate per 1000 population of whole
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Figure 1: Estimated Rates of Whole Blood and RBC Collections and Transfusions in the US from 1992 to
2013 (Chung et al. (2016))
blood and RBC units collected and transfused in the US over the 1992-2013 period. In the
United States, the American Red Cross supplies about 40% of the blood, with America’s
Blood Centers, with 600 blood donor centers, providing about 50% (and about one quarter
of the blood in Canada) (cf. American Red Cross (2016)). The remainder is collected by
hospitals and medical centers themselves or, lately, by profit-maximizing blood suppliers
(see, e.g., Carlyle (2012)).
Among the strategic responses of blood banks to the decreasing demand has been to
downsize their operations at various stages of their supply chains. As part of this strategy,
during a period of only a few years, the Red Cross consolidated their 5 national testing labs
into 3, in addition to consolidating their manufacturing zones from 7 to 4. These consoli-
dations were also applied at the regional division level to better coordinate the operations
across those zones (Meyer (2015)). The Red Cross is also holding fewer mobile blood drives
and, instead, operates larger blood collection sites in an effort to increase the efficiency of
their supply chain (Meyer (2015)).
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A rapidly accelerating trend in the blood banking industry over the past few years is the
formation of partnerships between the suppliers at a variety of depths and different configu-
rations. According to the America’s Blood Centers, nearly 20 partnerships and mergers were
formed in the 2010-2015 period among their member blood banks (reducing the size of the
network from 87 to 68 members). It is interesting to note that only 19 mergers took place
during the 1990s (America’s Blood Centers (2015)). Even outside of the America’s Blood
Centers network, the formation of partnerships between blood banks demonstrates that the
industry is currently going through a wave of mergers (Carden (2009)). For example, in
April 2010, the Blood Center of Iowa and the Sioux Fall Blood Bank merged operations to
become the LifeServe Blood Center (LifeServe Blood Center (2016)). In August 2013, The
American Red Cross acquired Delta Bank, which was a nonprofit blood bank serving several
counties in California (Bonnett (2013)). In September 2013, five nationally recognized blood
centers announced the formation of a new alliance known as the HemeXcel Purchasing Al-
liance LLC., with a goal towards cost savings (BloodWorks Northeast (2013)). In December
2015, San Francisco’s blood bank and Sacramento’s BloodSource announced their merger
plan (Robertson (2015)).
In July 2014, OneBlood, Inc., a blood center serving Florida, Georgia, and Alabama,
and The Institute for Transfusion Medicine, Inc. (ITxM), a blood center operating in Penn-
sylvania, Illinois, Virginia, Ohio, and West Virginia, announced that they had reached an
agreement to pursue a merger of the two organizations. According to officials, the two blood
banks were seeking enhanced safety, availability, and affordability of blood for their hospital
partners and the patients through the merger process. It is interesting that both organiza-
tions (or their parent organizations) had undergone a number of mergers and acquisitions
of their own in the past (Lifesource (2014)). Later that year, the two parties suspended the
merger talks after “several months of thorough and careful due diligence” on the feasibility
of the merger. In August 2015, OneBlood announced another merger, this time with The
Blood Alliance, Inc., a smaller blood center located in Jacksonville. This merger expanded
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OneBlood’s reach in North Florida, deeper into Georgia, Alabama as well as South Carolina
(Anguiano (2015)). Given the changes in the blood services landscape in the United States
and the growing number of mergers and acquisitions between blood service organizations,
this paper focuses on identifying potential operational efficiency synergies associated with
such M&As. The specific pending M&A that that we utilize to illustrate the applicability
of our methodological framework is that of OneBlood, Inc., and ITxM.
2. Literature Review
In this section we review the relevant articles in the area of blood supply chains in addition
to the literature corresponding to network optimization and blood supply chains as well as
mergers and acquisitions.
2.1 Blood Supply Chains
Perishable products, in general, and human blood, in particular, from a supply chain
perspective, have long been studied by numerous researchers. Among the remarkable early
works in the area of perishable product supply chains is the paper of Nahmias and Pierskalla
(1973), which developed a multiperiod ordering model for a perishable product with a fixed
lifetime. Federgruen, Prastacos, and Zipkin (1986), in turn, presented a combined problem
for the allocation and distribution of a perishable product from a regional distribution center
to a given set of locations with random demands.
Nahmias (2011), Karaesmen, Scheller-Wolf, and Deniz (2011), Belien and Force (2012), as
well as Osorio, Brailsford, and Smith (2015) have done comprehensive reviews of the perish-
able products supply chain management literature including the study of various inventory
policies in the blood banking systems.
Jacobs, Silan, and Clemson (1996), Pierskalla (2004), and Ghandforoush and Sen (2010)
are among the papers that discuss the application of integer programming optimization mod-
els for the operations/design/redesign of blood supply chains. These models are generally
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used to address the facility location problem, routing problems, set covering, and the al-
location of whole blood and other blood products. Furthermore, Amorim, Gunther, and
Almada-Lobo (2012) presented an integrated approach for the production and distribution
of highly perishable products using a multi-objective mixed-integer programming framework.
As noted by Belien and Force (2012), simulation techniques have gained popularity among
researchers of blood banking systems due to the inherent complexity of inventory manage-
ment in such systems. Rytila and Spens (2006) and Mustafee, Katsaliaki, and Brailsford
(2009) are among the notable simulation works in the area of blood supply chains. Further-
more, Duan and Liao (2014) developed a simulation optimization framework for the inventory
management of blood while taking into account the ABO blood group compatibility.
Van Dijk et al. (2009) used a Markov dynamic programming and simulation approach for
the production of platelets with data from Dutch blood banks. Haijema (2014) presented a
stochastic dynamic programming model for perishable product inventory by introducing an
optimal stockage dependent ordering and disposal policy. Pauls-Worm et al. (2016) modeled
a single-item, single-echelon production planning problem of a perishable product with a
fixed life-time using a stochastic programming technique with a chance constraint. More
recently, Dillon, Oliveira, and Abbasi (2017) proposed a two-stage stochastic programming
model with recourse for supporting hospital’s inventory management decisions in the blood
supply chain. The model was reformulated and solved as a mixed integer linear programming
problem. Hosseinifard and Abbasi (2016), in turn, consider uncertainty on the supply side
and on the demand side and demonstrate that the number of hospitals serviced by the blood
bank has a significant impact on the performance of the supply chain. Also, the authors’
results reveal that centralizing the hospitals may improve the outdate at hospitals and the
shortage at hospitals and the blood bank.
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2.2 Network Optimization and Blood Supply Chains
Network optimization methods have been widely used of late in modeling the design
and operations of blood banking systems. This is mainly due to the versatility of such
models in capturing various complexities of large blood supply chain networks in addition to
the applicability of solution algorithms from the domain of network theory. Nagurney et al.
(2013) presented an analytical framework for the supply chain of several perishable and time-
sensitive products including blood banking systems. Jabbarzadeh, Fahimnia, and Seuring
(2014) proposed a network optimization approach for the location-allocation problem of
blood banks after natural disasters such as earthquakes. Nagurney, Masoumi, and Yu (2012)
constructed a multicriteria supply chain network model for the operations management of a
regional blood bank subject to uncertain demand while minimizing the overall cost as well as
the supply-side risk. A generalized network approach with arc multipliers was utilized in that
model to capture the perishability/loss/waste during various activities of the blood supply
chain. Nagurney and Masoumi (2012) developed a supply chain optimization model for the
design/redesign problem of a sustainable blood bank under various scenarios of uncertain
demand.
2.3 Mergers and Acquisition Policies
Concurrent with the wave of mergers and acquisitions in various industries, several re-
searchers have studied the process of a merger – however, mostly in the context of commercial
supply chains. Kumar (2009) compared numerous cases of mergers and acquisitions in de-
veloped countries to those in emerging economies from a strategic perspective. Cho (2014)
analyzed the effects of a merger in a decentralized supply chain concluding that attention
should be paid to where a merger takes place in a supply chain, and to whether a supply chain
is led by upstream or downstream firms. Comez-Dolgan and Tanyeri (2015) in their study
of 270 cases of mergers of American companies over a period of three decades found that
the inventory turnover of the merging firms improves once a successful merger is complete
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as a result of greater economies of scale. In the context of healthcare systems, Zucker-
man (2011) identified the key forces reshaping the industry including the insurance industry
consolidation and cost inflation in a period of integration for healthcare organizations.
In their book chapter, Havila and Salmi (2002) investigated international mergers and ac-
quisitions from a network perspective, and suggested that failures in such integration efforts
might be a result of the influences of the merging companies’ network contexts. Mattsson
(2003) stated that a network view of the supply chain would help in analyzing the potential
reasons for the success and failure of integration in globalized markets. Nagurney (2009)
presented a system-optimization framework for the quantification of strategic advantages as-
sociated with horizontal mergers. Nagurney and Qiang (2009) discussed a multicommodity
supply chain network model, which could be utilized to assess potential synergies associated
with the teaming of humanitarian organizations for disaster relief. Nagurney (2010), subse-
quently, considered competitive firms in an oligopolistic supply chain network setting and
quantified synergies associated with mergers with the goal of explaining the merger paradox.
Nagurney and Woolley (2010) developed a multicriteria supply chain network framework to
assess the environmental effects of a merger or acquisition as well as the resulting synergy
from possible strategic gains. Liu and Nagurney (2011) constructed a supply chain network
framework to quantify the potential gains through integration in terms of risk reduction and
cost synergy using a mean-variance approach. Oberg, Henneberg, and Mouzas (2007) and
Zhang et al. (2010) are among the other notable studies that investigate pre-merger and
post-merger issues from a network perspective.
This paper is the first to present a mathematical framework for the modeling of a merger
or acquisition between two or more blood banks as well as the acquisition of a blood bank
by another organization. The developed framework enables the decision-makers of blood
banking systems to fully investigate the pros and cons of a potential merger or acquisition
with respect to the goals of operational efficiency at a time of reduced demand, as is being
faced by the industry, as well as at a time of a natural disaster, terrorist attack, or pandemic,
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when there may be a surge in demand. The number of disasters is growing as well as the
number of people impacted (cf. Nagurney and Qiang (2009)) and, hence, preparing for them
and having a sustainable blood supply is of critical importance (see Mulcahy et al. (2016)).
The proposed models in this paper are built on a network optimization platform with arc
multipliers representing the throughput of product flow subject to the perishability/waste/
loss of blood across the supply chain. In both the pre-merger and post-merger problems,
the organizations aim to minimize the total operational and discarding costs subject to
the uncertain demand being satisfied as closely as possible. Moreover, we present specific
efficiency measures to evaluate the extent of success of a potential merger or acquisition
taking into account the total cost as well as the shortage/surplus of blood units in the pre-
and post-merger models, while capturing perishability. Another contribution of this paper
to the blood supply chain literature is the inclusion of the frequency associated with each
supply chain activity as a decision variable in the model. We note that the idea of activity
frequency has been utilized in other applications of network theory (see, e.g., Nagurney, Yu,
and Floden (2013) and Nagurney (2015)), but not in the case of mergers and acquisitions or
in the case of product perishability. Given the existing capacities, the frequency associated
with a supply chain activity, be it collection, testing and processing, storage, or distribution,
captures the repetition rate of that activity within a specified time interval.
The rest of this paper is organized as follows. In Section 3, we discuss the structure of the
blood banking system which includes the various associated activities of these critical supply
chains. Next, network topologies are provided to represent the cases of pre- and post-merger
between two or more blood banks. We construct the optimization formulations of both cases,
and then establish that the optimization problems are equivalent to variational inequality
problems. Such an association provides us with an effective computational framework. The
efficiency measures are also discussed in this section. In Section 4, we present a large-scale
numerical example for the case of a merger between two blood banks. The algorithm which
yields the optimal level of blood product flows in the supply chain network(s) as well the
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frequencies of the activities in the supply chain, before and after the merger, is given, for
completeness, in the Appendix. We then apply the proposed algorithm to compute the
solution to both problems in order to illustrate the modeling and analyze the efficiency and
responsiveness of the merger/acquisition from different perspectives, including the occurrence
of a disaster. We also discuss the significance of the results. In Section 5, we present our
conclusions.
3. The Supply Chain Network Model of a Blood Bank Merger or Acquisition
We first present the supply chain network model for a blood bank and then its merger/ac-
quisition counterpart. Without loss of generality, we can assume that our model represents
the blood banking system of a regionalized blood bank (in case of a large organization such
as the American Red Cross Blood Services with multiple regions across the country), or an
autonomous blood center (such as one chapter of the America’s Blood Centers serving one
or a few neighboring states). Even though our network framework is sufficiently general
to capture any vertically integrated blood supply chain network, it should be noted that
these modules might be called differently from one organization to another. Furthermore,
the proposed supply chain network model for blood banking systems with arc multipliers
and frequencies of supply chain activities can also be adapted to other perishable products
(see, e.g., the case of fresh produce in Yu and Nagurney (2013) and that for medical nuclear
products in Nagurney and Nagurney (2012)).
3.1 Overview of the Supply Chain of a Blood Bank
In order to be consistent with the majority of real-world cases, we consider a blood banking
system that conducts and distributes blood in a regional manner (cf. Nagurney, Masoumi,
and Yu (2012)). In our model, there exists a Blood Bank serving a specific geographic area
which is also in charge of administration of its lower-level units. The blood bank could also
be called a Blood Chapter, or a Blood Organization depending on the case. We refer to it as
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an “organization” henceforth in this paper. Figure 2 depicts a supply chain network topology
corresponding to the pre-merger problem consisting of I organizations. In this topology, the
top level node (origin) of each organization represents the blood chapter management or the
regional division management. Every other node within the network of each organization
denotes a facility in the system. For every organization i ∈ {1, . . . , I} there exist one or more
paths, each of which connects the corresponding origin node i to one of its destination nodes,
that is, the demand nodes representing the hospitals or medical centers. This assumption
guarantees that the uncertain demand for blood at each such facility will be met as closely
as possible. Every path consists of a sequence of directed links representing the supply
chain network activities starting with the collection of blood all the way to the distribution.
According to Figure 2, each organization services, pre-merger, a different set of demand
points.
Next, we present a brief description of the activities taking place between every two tiers
of the facilities belonging to Organization i; i ∈ {1, . . . , I}, as depicted in Figure 2. The
links/arcs connecting these nodes (facilities) represent the five major activities in the blood
supply chain as described below:
• Blood Collection: occurs in either mobile or permanent blood “collection sites” or
“donor centers” and is represented by the set of links connecting each top node to
the collection sites. We assume Organization i has nic of such facilities denoted by
Ci1, C
i
2, . . . , C
i
niC
.
• Shipment : is displayed by the second set of links connecting the second and the third
tier of nodes, and captures the process of shipping the collected units of whole blood
(WB) to niB “blood centers” of Organization i denoted by B
i
1, B
i
2, . . . , B
i
niB
.
• Testing and Processing : are typically done concurrently yet at different locations some-
times hundreds of miles away. Processing refers to the separation of the collected blood
12
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Figure 2: Supply Chain Network Topology for I Blood Organizations in the Pre-Merger Problem
into parts (red blood cells, white blood cells, plasma and platelets) at niP “manufac-
turing labs” of Organization i denoted by P i1, P
i
2, . . . , P
i
niP
. Also known as “component
labs”, manufacturing labs are very often located within the blood center locations.
Testing, unlike processing, is conducted at the “testing labs” to which a small sam-
ple of every unit of collected blood is sent overnight. These samples are discarded
regardless of the test result once the tests are over, and, in our model, the respective
amounts of waste are addressed using the arc multipliers. The cost on these sets of
links represents the operational cost of testing and processing combined.
• Storage: refers to the short-term storing of processed units of red blood cells (RBC)
in one of the niS “storage facilities” of Organization i before being distributed. In the
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proposed network topology for a blood bank, storage facilities are located on the fifth
tier of the nodes, and are denoted by Si1, S
i
2, . . . , S
i
niS
. Note that, in practice, storage
facilities are usually located in the same place as the manufacturing labs, serving as
“distribution centers” in the blood supply chain.
• Distribution: corresponds to the last set of links connecting the bottom two tiers of
nodes in the supply chain network topology, and captures the delivery of the red blood
cells to niR “demand points” served by Organization i in the pre-merger problem.
Hospitals and other medical surgical centers denoted by Ri1, R
i
2, . . . , R
i
niR
constitute our
demand points.
It is necessary to emphasize that the proposed supply chain network topology is process-
based rather than location-based. As mentioned earlier, specific modules of the blood bank-
ing system belonging to one organization may physically coincide with some others of the
same organization. The ultimate solution of the complete model yields the optimal flows of
blood on various links of the network as well as the optimal frequency of such activities at
minimum total cost. Next, we present the mathematical model that captures the pre-merger
problem, beginning with the notation utilized.
3.2 Mathematical Model for the Pre-Merger Blood Banking Problem
In the proposed model for the pre-merger problem, there exists a total of I blood banking
organizations. Detailed definitions of the notation are given in Table 1.
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Table 1: Notation for the Pre-Merger Blood Banking Problem
Notation Definition
Sets:
Gi = [Ni, Li] The graph consisting of nodes Ni and directed links Li
representing the activities associated with each Organi-
zation i; i = 1, . . . , I.
G0 = [N0, L0] The graph consisting of the set of nodes and the set of
links in the topology for the pre-merger problem; that
is, G0 = [N0, L0] = ∪i=1,...,I [Ni, Li]. nL0 denotes the
number of all the links.
P0
Rik
The set of paths joining the top node of each Or-
ganization i to a specific demand node; i.e., the ori-
gin/destination pair (i, Rik); i = 1, . . . , I and k =
1, . . . , niR.
P0 The set of all paths in the pre-merger problem (Figure
2). nP0 denotes the number of all paths.
Parameters:
dik The stochastic parameter representing the actual de-
mand for red blood cells (RBC) at demand market Rik;
i = 1, . . . , I and k = 1, . . . , niR during the time period of
one week.
u¯a The existing capacity of link a; a ∈ L0.
δap δap = 1, if link a is contained in path p and δap = 0,
otherwise; a ∈ L0 and p ∈ P0.
αa The arc multiplier associated with link a, which repre-
sents the percentage of throughput on link a. αa ∈ (0, 1];
a ∈ L0.
αap The arc-path multiplier, which is the product of the mul-
tipliers of the links on path p that precede link a; a ∈ L0
and p ∈ P0; that is,
αap ≡

δap
∏
b∈{a′<a}p
αb, if {a′ < a}p 6= Ø,
δap, if {a′ < a}p = Ø,
where {a′ < a}p denotes the set of the links preceding
link a in path p.
µp The multiplier corresponding to the percentage of
throughput on path p; that is, µp ≡
∏
a∈p
αa; p ∈ P0.
λ−ik The penalty associated with the shortage of a unit of
blood at demand point Rik; i = 1, . . . , I and k =
1, . . . , niR.
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Notation Definition
λ+ik The penalty associated with the surplus of a unit of
blood at demand point Rik; i = 1, . . . , I and k =
1, . . . , niR.
Decision Variables:
vik The projected demand for RBC at the demand point R
i
k;
i = 1, . . . , I and k = 1, . . . , niR during the time period
of one week. We group the projected demands into the∑I
i=1 n
i
R-dimensional vector v.
xp The nonnegative flow of RBC on path p; p ∈ P0. We
group the path flows into the nP0-dimensional vector x.
fa The initial flow of RBC on link a; a ∈ L0. We group the
link flows into the nL0-dimensional vector f .
γa The activity frequency of link a; a ∈ L0 in the time
period. We group the activity frequencies into the nL0-
dimensional vector γ.
Functions:
cˆa = cˆa(fa, γa) The total operational cost on link a which is assumed to
be a function of the product flow on that link as well as
the activity frequency of that link; a ∈ L0.
Fik(t) The probability density function of the actual demand
at demand market Rik; i = 1, . . . , I and k = 1, . . . , n
i
R.
Pik(vik) The cumulative distribution function of dik; that is,
Pik(vik) = Pik(dik ≤ vik) =
∫ vik
0
Fik(t)d(t).
zˆa = zˆa(fa) The total discarding cost function associated with the
product flow on link a; a ∈ L0.
∆−ik = ∆
−
ik(vik) The shortage of blood at demand point R
i
k; that is,
∆−ik ≡ max{0, dik − vik}; i = 1, . . . , I and k = 1, . . . , niR.
The expected shortage is given by E(∆−ik) =
∫∞
vik
(t −
vik)Fik(t)d(t).
∆+ik = ∆
+
ik(vik) The surplus of blood at demand point R
i
k; that is,
∆+ik ≡ max{0, vik − dik}; i = 1, . . . , I and k = 1, . . . , niR.
The expected surplus is given by E(∆+ik) =
∫ vik
0
(vik −
t)Fik(t)d(t).
The total operational cost functions and the total discarding cost functions of all links
are assumed to be convex and continuously differentiable.
In the model, αa represents the throughput of product flow on link a subject to the
percentage of perishability/waste/loss on that link (activity). For example, if the expected
percentage of waste during the testing and processing phase of a blood center is 5%, the
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corresponding throughput factor, αa, will be 0.95. Given the network topology, the following
conservation of flow constraints must hold across the supply chain of all blood organizations:
fa =
∑
p∈P0
xpαap, ∀a ∈ L0. (1)
Equation (1) states that the initial product flow (excluding waste/perishability/loss) on link
a is the sum of the product flows along paths which contain that link, with the consideration
of possible losses in the preceding activities.
Furthermore, each organization determines the shipments of blood product based on the
projected demand at its own demand points subject to the throughput factor on its paths,
which must satisfy the following conservation of flow equation:
vik =
∑
p∈P0
Ri
k
xpµp, i = 1, . . . , I; k = 1, . . . , nR. (2)
Note that in our model, the flow on each link a; i.e., fa, represents the number of units of
red blood cells (RBC) on that link (rather than the number of units of whole blood (WB))
subject to the waste/loss on the preceding links. As a matter of fact, over the first three sets
of links (blood collection, shipment of collected blood, as well as testing and processing) the
unprocessed whole blood constitutes the product whereas in the bottom two tiers of links
(storage and distribution), we have the processed blood cells. This assumption is in line
with the real-world problem as one unit (one pint) of collected whole blood can be separated
into one unit of red blood cells in addition to plasma, platelets, and other by-products of
the human blood. Similarly, the value of path flow, xp, as well as the actual and projected
demand at demand market Rki ; i.e., dik and vik, respectively, represent the number of units
of red blood cells corresponding to that path or that demand point.
It should also be noted here that the focus of this paper is on the supply chain of red
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blood cells rather than the other derivatives of blood. This is mainly due to the fact that
various derivatives of blood have very different shelf-lives (5 days for platelets, 5-6 weeks
for whole blood and red blood cells, and up to a year for plasma when kept frozen). With
red blood cells constituting the majority of transfusions among all products of blood (cf.
Whitaker (2011)), we exclude the other derivatives from our model. In addition, platelets
and plasma can be obtained during a different process called apheresis in which blood is
passed through an apparatus separating out one particular constituent - plasma or platelets
– and returning the remainder to the donor.
In addition, the path flows must be nonnegative; that is,
xp ≥ 0, ∀p ∈ P0. (3)
The model assumes a capacity for every link of the blood supply chain networks. These
capacities reflect the upper bound on the volume of various activities – collection, shipment,
and so forth during a period (of one week). Given the existing link capacities, our model
guarantees that the flow on each link does not exceed the effective capacity (subject to the
frequency of that activity) in that time period. Thus, the following constraints must hold:
fa ≤ u¯aγa, ∀a ∈ L0. (4)
For each organization, the total cost minimization objective faced by the organization
includes the total cost of operating the various links, the total discarding cost of waste over
the links, and the expected total blood supply shortage cost as well as the total discarding
cost of outdated blood at the demand points. Since the optimization problems for the
organizations are independent, the solution of the following optimization problem, also yields
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the optimal solution for each Blood Organization i; i = 1, . . . , I,
Minimize
I∑
i=1
∑
a∈Li
cˆa(fa, γa) +
I∑
i=1
∑
a∈Li
zˆa(fa) +
I∑
i=1
niR∑
k=1
(
λ−ikE(∆
−
ik) + λ
+
ikE(∆
+
ik)
)
, (5)
subject to: constraints (1)–(4).
We define ηa; a ∈ L0 as the Lagrange multipliers associated with constraint (4); and we
group the Lagrange multipliers into the nL0-dimensional vector η. We know that the objective
function (5) for each i = 1, . . . , I, is convex under our imposed assumptions on the total
operational cost and the total discarding cost functions since
∑niR
k=1
(
λ−ikE(∆
−
ik) + λ
+
ikE(∆
+
ik))
is also convex, as established in Nagurney, Masoumi, and Yu (2012), and the sum of convex
functions is also a convex function.
We now present the variational inequality formulation of the above optimization problem,
once, in terms of path flows and, then, link flows. The proof is in the Appendix. We provide
the variational inequality (VI) formulation since it then allows us to exploit the special
structure for computational purposes.
Theorem 1: Variational Inequality Formulation
The optimization problem (5), subject to (1) through (4), is equivalent to the variational
inequality problem: determine the vector of optimal path flows, the vector of optimal activity
frequencies, and the vector of Lagrange multipliers, (x∗, γ∗, η∗) ∈ K, such that:
I∑
i=1
niR∑
k=1
∑
p∈P0
Ri
k
∂Cˆp(x∗, γ∗)
∂xp
+
∂Zˆp(x
∗)
∂xp
+ λ+ikµpPik
 ∑
q∈P0
Ri
k
x∗qµq

−λ−ikµp
1− Pik
 ∑
q∈P0
Ri
k
x∗qµq

+∑
a∈Li
η∗aαap
× [xp − x∗p]
+
I∑
i=1
∑
a∈Li
[
∂Cˆp(x
∗, γ∗)
∂γa
− u¯aη∗a
]
× [γa − γ∗a]
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+
I∑
i=1
∑
a∈Li
u¯aγ∗a − ∑
q∈P0
x∗qαaq
× [ηa − η∗a] ≥ 0, ∀(x, γ, η) ∈ K, (6)
where K ≡ {(x, γ, η)|x ∈ RnP0+ , γ ∈ RnL0+ , η ∈ RnL0+ } and for each path p; p ∈ P0Rik ; i =
1, . . . , I; k = 1, . . . , niR,
∂Cˆp(x, γ)
∂xp
≡
∑
a∈Li
∂cˆa(fa, γa)
∂fa
αap, (7a)
∂Zˆp(x)
∂xp
≡
∑
a∈Li
∂zˆa(fa)
∂fa
αap. (7b)
For each link a; a ∈ Li; i = 1, . . . , I,
∂Cˆp(x, γ)
∂γa
≡ ∂cˆa(fa, γa)
∂γa
. (7c)
The variational inequality (6), in turn, can be rewritten in terms of link flows as: deter-
mine the vector of optimal link flows, the vector of optimal projected demands, the vector
of optimal activity frequencies, and the vector of Lagrange multipliers, (f ∗, v∗, γ∗, η∗) ∈ K1,
such that:
I∑
i=1
∑
a∈Li
[
∂cˆa(f
∗
a , γ
∗
a)
∂fa
+
∂zˆa(f
∗
a )
∂fa
+ η∗a
]
× [fa − f ∗a ]
+
I∑
i=1
niR∑
k=1
[
λ+ikPik(v
∗
ik)− λ−ik(1− Pik(v∗ik))
]× [vik − v∗ik]
+
I∑
i=1
∑
a∈Li
[
∂cˆa(f
∗
a , γ
∗
a)
∂γa
− u¯aη∗a
]
× [γa − γ∗a]
+
I∑
i=1
∑
a∈Li
[u¯aγ
∗
a − f ∗a ]× [ηa − η∗a] ≥ 0, ∀(f, v, γ, η) ∈ K1, (8)
where K1 ≡ {(f, v, γ, η)|∃x ≥ 0, (1)− (3) hold, and γ ≥ 0, η ≥ 0}.
20
3.3 Mathematical Model for the Post-Merger Blood Banking Problem
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Figure 3: Supply Chain Network Topology for the Post-Merger Problem
We now consider the situation where the I individual blood organizations have merged to
form a new organization as shown in Figure 3. We denote the network topology for the post-
merger problem by G1 = [N1, L1] where N1 = N0 ∪ node 0, L1 = L0 ∪ the additional links,
and nL1 is the number of the links in this new topology. Supernode 0 represents the newly
merged blood banking organization. The links connecting node 0 and node i; i = 1, . . . , I
reflect the merger of those blood organizations. Since the focus of this model is on the
operational aspects associated with the merger, we assume that the total costs associated
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with merging are negligible. If the merger/acquisition costs are to be incorporated then they
would be assigned to the uppermost links in the network in Figure 3.
Once the merger (or acquisition) is complete, collection sites of Organization i (which no
longer exists as an individual entity) will have the option to transport the collected units
of whole blood to the blood centers of the other organization(s) for subsequent testing,
processing, etc. The solution of the model will determine whether or not this leads to cost-
saving for the merged organization. In Figure 3, the newly added cross-organizational links
connecting the third and the fourth tiers of facilities enable such added capabilities which
are an immediate outcome of a completed merger or acquisition. Furthermore, the newly
added links between the last two tiers of facilities in the network reveal that Organization
i will now be able to serve the hospitals and medical centers under contract with the other
blood provider(s), assuming that the optimal solution recommends this.
The solution to the model with the two new sets of links in the post-merger problem allows
for an a priori evaluation of whether one can expect an improved operational efficiency for
the blood organizations as well as an enhanced stability of the blood supply. These outcomes,
as expressed earlier in the introduction, are among the major motives for the blood banks
to consider mergers and acquisitions.
Let P1
Rik
denote the set of the paths joining supernode 0 with demand point Rik; i =
1, . . . , I and k = 1, . . . , niR. P1 and nP1 denote the set of all the paths and the number of all
paths in the post-merger problem, respectively.
Consequently, the constraints (1)–(4) are updated for the new problem as follows:
fa =
∑
p∈P1
xp αap, ∀a ∈ L1, (9)
vik =
∑
p∈P1
Ri
k
xpµp, i = 1, . . . , I; k = 1, . . . , n
i
R, (10)
22
xp ≥ 0, ∀p ∈ P1, (11)
fa ≤ u¯aγa, ∀a ∈ L1. (12)
Therefore, for the merged blood organization, the total cost minimization problem can
be expressed as:
Minimize
∑
a∈L1
cˆa(fa, γa) +
∑
a∈L1
zˆa(fa) +
I∑
i=1
niR∑
k=1
(
λ−ikE(∆
−
ik) + λ
+
ikE(∆
+
ik)
)
, (13)
subject to: constraints (9)–(12).
Similar to the pre-merger model, the solution to the post-merger total cost minimization
problem can be obtained as a solution to a variational inequality problem akin to (6) (or
(8)) where now a ∈ L1, p ∈ P1
nik
, for i = 1, . . . , I, and k = 1, . . . , niR, and the vectors f ,
x, v, γ, η have identical definitions as before, but are re-dimensioned accordingly. Set K is
then replaced by K2 ≡ {(x, γ, η)|x ∈ RnP1+ , γ ∈ RnL1+ , η ∈ RnL1+ }; and set K1 is replaced by
K3 ≡ {(f, v, γ, η)|∃x ≥ 0, (9)− (12) hold, and γ ≥ 0, η ≥ 0}.
3.4 Efficiency Measures Associated with the Merger or Acquisition of the Blood
Organizations
In this section, we provide measures for the evaluation of the efficiency associated with
the merger or acquisition of the blood organizations. The measure that we utilize to capture
the gains, if any, is denoted by ET C, and is referred to as the total cost efficiency, defined as
follows:
ET C ≡
[
TC0 − TC1
TC0
]
× 100%, (14)
where TC0 and TC1 represent the optimal objective values of the pre-merger model and the
post-merger model, respectively. Note that ET C can be interpreted as synergy in terms of
cost savings (cf. Nagurney (2009), Nagurney and Woolley (2010), and Liu and Nagurney
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(2011)). The higher the value of ET C, the more beneficial the merger/acquisition.
In addition, we propose the following two measures, which capture the changes in the
supply shortage and surplus associated with the merger or acquisition:
S− =
[
S0− − S1−
S0−
]
× 100%, (15)
S+ =
[
S0+ − S1+
S0+
]
× 100%, (16)
where S0− and S1− represent the expected total supply shortage costs (penalties) associated
with the pre-merger model and the post-merger model, respectively, i.e.,
∑I
i=1
∑niR
k=1 λ
−
ikE(∆
−
ik),
with the E(∆−ik) values evaluated at the optimal solution for the pre-merger problem for S
0−
and at the optimal solution for the post-merger problem for S1−. S0+ and S1+, in turn,
represent the expected total supply surplus costs associated with the pre-merger model and
the post-merger model, respectively, that is,
∑I
i=1
∑niR
k=1 λ
+
ikE(∆
+
ik) with the E(∆
+
ik) values
evaluated at the optimal solution for the pre-merger problem for S0+ and for the post-merger
problem for S1+.
4. Case Study: A Merger Between Two Blood Banking Systems
In order to illustrate the proposed framework for the merger/acquisition between two
or more blood banking systems, we are inspired by the recent pending case of the merger
between OneBlood, Inc., and The Institute for Transfusion Medicine, Inc. (ITxM). As
mentioned earlier in the Introduction, the two blood banks announced their agreement to
pursue a merger in July 2014 which would create the largest independent not-for-profit
blood center in the United States distributing nearly 2 million units of blood annually, with
combined revenues of $480 million and employing more than 3,500 people. The merger
process is said to have become suspended in 2015 - as discussed earlier in the text. Through
the following case study, we analyze the potential benefits as well as the risks the two blood
organizations would take as a result of the merger under a status quo scenario and also in
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the case of a disaster.
Based in Orlando, Florida, OneBlood is the larger of the two organizations, with about
2,000 employees and $295 million in revenues. Distributing nearly one million units of
blood annually, OneBlood serves about 200 hospital partners, covering 80 percent of Florida
and parts of Alabama and Georgia. Samples of all blood units – collected in their 80
donor centers or their 200 specialized big red buses – are delivered via a OneBlood courier
to the Creative Testing Solutions (CTS), the state-of-the-art testing facility located in St.
Petersburg, Florida. As mandated by the Federal laws, more than a dozen of tests are
conducted on every sample in a period of 12–14 hours, including screening for Zika virus. Test
results are sent back to the blood centers in less than 24 hours. OneBlood owns 9 biologics
manufacturing labs (component labs) spread across the region. On average, OneBlood sends
around 1,000 deliveries daily to their partner hospitals 24 hours a day, 7 days a week, 365
days a year. It typically takes an additional 2-3 days for the delivered blood to be transfused
to a patient in need (Oneblood.org (2016)).
The other organization involved in the merger, The Institute for Transfusion Medicine,
Inc. (ITxM), is one of the nation’s foremost nonprofit organizations specializing in transfu-
sion medicine and related services. It operates in Pittsburgh, Chicago, Virginia, and parts of
Ohio, and West Virginia serving over one million units of blood components to the hospitals
in the region. ITxM has multiple blood centers including: (1) LifeSource located in Chicago
providing over a half million blood products to approximately 60 hospitals across Illinois,
and (2) Central Blood Bank located in Pittsburgh distributing more than 160,000 units of
blood annually to more than 40 hospitals from the blood collected in their 25 community
donor centers (The Institute for Transfusion Medicine (2016)).
For the numerical example corresponding to the pre-merger problem, without loss of gen-
erality, we focus on a fraction of the facilities belonging to the actual supply chain network
of the two aforementioned organizations. It should be emphasized that the presented mod-
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eling framework as well as the developed mathematical formulation in Section 3 can capture
the case of merger/acquisition between any number of blood organizations consisting of any
given number of facilities.
As seen in Figure 4, Organization 1, representing OneBlood, Inc., in our pre-merger
problem, is composed of three blood collection sites, one of which (C11) is a permanent donor
center, and the other two are assumed to be big red buses (C12 and C
1
3). In addition, there
exist two blood centers, two manufacturing labs, two storage facilities, and two hospitals in
the supply chain network of OneBlood, Inc. We assume Blood Center B11 , Manufacturing
Lab P 11 , and Storage Facility S
1
1 are all located in a consolidated facility in Fort Lauderdale
area whereas B12 , P
1
2 , and S
1
2 are located in Tampa. R
1
1 and R
1
2 are the two partner hospitals
also located in Florida, large and medium-size, respectively. We consider a time horizon of
a week since we are interested in a potential M&A and such a time period is more reflective
of supply chain activities than a single day. The weekly demand for red blood cells is
assumed to follow a continuous uniform distribution on the intervals [200,400] and [150,250],
respectively. Thus, the cumulative distribution functions corresponding to these demand
points are as follows:
P11
( ∑
p∈P0
R11
µpxp
)
=
∑
p∈P0
R11
µpxp − 200
400− 200 , P12(
∑
p∈P0
R12
µpxp) =
∑
p∈P0
R12
µpxp − 150
250− 150 ,
where P0
R11
and P0
R12
represent the sets of paths connecting the top node of Organization 1,
One Blood, Inc., with the two demand points in the pre-merger problem. Each of these sets
contains 6 paths demonstrating 6 possible sequences of links corresponding to each demand
point. Furthermore, G1 = [N1, L1], the graph corresponding to Organization 1 in the pre-
merger problem, consists of 12 nodes in N1 and 17 directed links in L1 as seen in Figure
4.
Similarly, Organization 2, representing ITxM, is composed of two collection sites, two
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Organization 1: One Blood, Inc.
k1 k
Organization 2: ITxM
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Figure 4: Supply Chain Network Topology for the Pre-Merger Problem in the Case Study
blood centers, two manufacturing labs, two storage facilities, and two hospitals. Similar to
the other organization, each blood center is assumed to be co-located with one manufactur-
ing lab and one storage facility. Thus, the first consolidated facility (housing B21 , P
2
1 , and
S21) is located in Chicago, and the other one (consisting of B
2
2 , P
2
2 , and S
2
2) is in Pittsburgh.
Weekly demand at their two partner hospitals, R21 and R
2
2 located in Chicago and Pitts-
burgh, respectively, are assumed to follow a continuous uniform distribution on the intervals
[220,370] and [80,110] representing a large hospital and a small surgical center, respectively.
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The cumulative distribution functions corresponding to these demand points are:
P21
( ∑
p∈P0
R21
µpxp
)
=
∑
p∈P0
R21
µpxp − 220
370− 220 , P22(
∑
p∈P0
R22
µpxp) =
∑
p∈P0
R22
µpxp − 80
110− 80 ,
where P0
R21
and P0
R22
represent the sets of paths connecting the top node of Organization 2; i.e.,
ITxM, with its demand points in the pre-merger problem. Each of these sets contains 4 paths
corresponding to each demand point. Similarly, G2 = [N2, L2], the graph corresponding to
Organization 2 in the pre-merger problem, consists of 11 nodes in N2 and 14 directed links
in L2.
In total, nP0 , the number of paths in the pre-merger problem corresponding to both
organizations combined, is equal to 2 × 6 + 2 × 4 = 20. Also, G0 = [N0, L0], the graph
consisting of the set of all nodes and links in the topology for the pre-merger problem is
composed of 17 + 14 = 31 links where links {1 − 17} and {18 − 31} belong to L1 and L2,
respectively.
The shortage penalties for each of the four demand points reflecting the relative severity
of the consequences of shortage of one red blood cell unit at these hospitals and surgical
centers are as follows (See Masoumi (2013) for a thorough sensitivity analysis of unit shortage
penalties):
λ11
−
= 7, 000, λ12
−
= 6, 000, λ21
−
= 8, 000, and λ22
−
= 3, 700.
Similarly, the outdating penalties representing the extra cost each of the four hospitals incur
in case of the surplus of one unit of red blood cells are (cf. Masoumi (2013)):
λ11
+
= 50, λ12
+
= 60, λ21
+
= 40, and λ22
+
= 75.
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The multipliers corresponding to the link throughputs (αa;∀a ∈ L0), the existing link
capacities (u¯a;∀a ∈ L0), the total operational cost functions (cˆa(fa, γa);∀a ∈ L0), and the
total discarding cost functions (zˆa(fa);∀a ∈ L0) are as reported in Tables 2 and 3. Table 2
demonstrates the data for Organization 1 (OneBlood, Inc.) whereas Table 3 shows the data
for Organization 2 (ITxM). The parameters and functions in the pre-merger problem were
determined using the available information on the above organizations’ websites as well as
the average historical data for the American Red Cross Northeast Division Blood Services
(cf. Nagurney, Masoumi, and Yu (2012)).
Table 2: Throughput Multipliers, Existing Weekly Capacities, Total Operational Cost and Total Discarding
Cost Functions for Organization 1 (OneBlood, Inc.) (Links 1-17) in the Pre-Merger Problem
Link a αa u¯a cˆa(fa, γa) zˆa(fa)
1 .97 200 .13(f1)
2 + .2f1 + (γ1)
2 .8f1
2 .98 225 .15(f2)
2 + .3f2 + 1.5(γ2)
2 .7f2
3 .99 225 .10(f3)
2 + .25f3 + (γ3)
2 .7f3
4 1.00 35 2f4 + 2γ4 0
5 .99 25 .35(f5)
2 + .8f5 + 9(γ5)
2 + 3γ5 .8f5
6 .99 40 1.4f6 + 4γ6 0
7 1.00 30 .05(f7)
2 + .1f7 + (γ7)
2 .7f7
8 .99 25 .18(f8)
2 + .4f8 + 3(γ8)
2 + 2γ8 .8f8
9 1.00 40 .85f9 + 2.5γ9 0
10 .96 1, 800 .55(f10)
2 + 2f10 + 3(γ10)
2 .8f10
11 .94 1, 600 .45(f11)
2 + 2.5f11 + 2(γ11)
2 .7f11
12 .99 2, 000 .07(f12)
2 + .5f12 + 2(γ12)
2 .8f12
13 .99 1, 600 .06(f13)
2 + .4f13 + 1.5(γ13)
2 .7f13
14 1.00 36 .9f14 + 3.5γ14 0
15 .99 40 .25(f15)
2 + 2.8f15 + 4.5(γ15)
2 + 4.5γ15 .8f15
16 .99 40 .12(f16)
2 + 2.5f16 + 4(γ16)
2 + 5γ16 .9f16
17 1.00 35 1.1f17 + 2.5γ17 0
In the Appendix, we outline the algorithm utilized to compute the optimal values of path
flows, activity frequencies, and Lagrange multipliers.
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Table 3: Throughput Multipliers, Existing Weekly Capacities, Total Operational Cost and Total Discarding
Cost Functions for Organization 2 (ITxM) (Links 18-31) in the Pre-Merger Problem
Link a αa u¯a cˆa(fa, γa) zˆa(fa)
18 .98 260 .11(f18)
2 + .3f18 + 2(γ18)
2 .6f18
19 .99 235 .13(f19)
2 + .2f19 + (γ19)
2 .7f19
20 1.00 25 f20 + .5(γ20)
2 + 4γ20 0
21 .99 35 .09(f21)
2 + .5f21 + (γ21)
2 + 4γ21 .8f21
22 .98 35 .14(f22)
2 + .9f22 + 1.5(γ22)
2 + 7.5γ22 .75f22
23 1.00 35 .8f23 + 3γ23 0
24 .95 2, 200 .6(f24)
2 + 1.1f24 + 2.5(γ24)
2 .6f24
25 .96 2, 000 .85(f25)
2 + 1.5f25 + 3(γ25)
2 .7f25
26 .99 2, 500 .05(f26)
2 + .4f26 + (γ26)
2 .6f26
27 1.00 2, 150 .06(f27)
2 + .6f27 + 2(γ27)
2 .5f27
28 1.00 30 .6f28 + 4γ28 0
29 .99 40 .1(f29)
2 + .5f29 + 2(γ29)
2 + 5γ29 .9f29
30 .99 35 .4(f30)
2 + 1.3f30 + 2(γ30)
2 + 6γ30 .7f30
31 1.00 40 .5f31 + 2.5γ31 0
4.1 Solution to the Pre-Merger Problem in the Case Study
We implemented the algorithm, the Euler method provided in the Appendix, using Mat-
lab to the described pre-merger problem to calculate the optimal values of link flows, link
frequencies, Lagrange multipliers, among other quantities of interest. The convergence toler-
ance was  = 10−5, and the sequence aτ = .1(1, 12 ,
1
2
, 1
3
, 1
3
, 1
3
· · · ). When the absolute value of
the difference between successive path flows, link frequencies, and Lagrange multipliers was
no more than the above , the algorithm was supposed to have converged. We initialized the
algorithm by setting each link frequency and Lagrange multiplier equal to zero. As for the
path flows, arbitrary positive values were assigned.
The optimal values for the above quantities for Organizations 1 and 2 in the pre-merger
problem can be found in Table 4.
As can be seen from the optimal link flows in Table 4, out of the 31 links belonging to the
two blood organizations, 5 have zero or very small flows meaning that such links (including 3
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Table 4: Optimal Values of the Weekly Link Flows, Weekly Frequencies of Activities, Lagrange Multipliers
as well as the Incurred Values of the Total Operational and Discarding Cost Functions for Organization 1
(OneBlood, Inc.) (Links 1-17) and Organization 2 (ITxM) (Links 18-31) in the Pre-Merger Problem
Organization 1 (OneBlood, Inc.) Organization 2 (ITxM)
Link a f ∗a γ
∗
a η
∗
a cˆa(f
∗
a , γ
∗
a) Link a f
∗
a γ
∗
a η
∗
a cˆa(f
∗
a , γ
∗
a)
+zˆa(f
∗
a ) +zˆa(f
∗
a )
1 204.95 1.02 .01 $5, 666.81 18 286.37 1.10 .02 $9, 280.89
2 179.42 .80 .01 $5, 009.04 19 214.48 .91 .01 $6, 174.23
3 297.12 1.32 .01 $9, 111.96 20 280.64 11.23 .61 $388.55
4 193.88 5.59 .08 $398.94 21 .00 .00 .11 $0.00
5 4.93 .20 .26 $17.31 22 22.60 .65 .27 $114.30
6 125.42 3.06 .17 $187.84 23 189.73 5.50 .12 $168.29
7 50.41 1.68 .11 $170.19 24 302.79 .14 .00 $55, 524.76
8 .00 .00 .08 $0.00 25 189.73 .09 .00 $31, 016.56
9 294.15 7.30 .04 $268.26 26 287.65 .11 .00 $4, 424.87
10 318.05 .18 .00 $56, 526.45 27 182.14 .08 .00 $2, 190.97
11 349.43 .22 .00 $56, 063.79 28 284.78 9.40 .04 $208.45
12 305.33 .15 .00 $6, 922.75 29 .00 .00 .05 $0.00
13 328.46 .21 .00 $6, 834.69 30 76.10 2.17 .42 $2, 491.03
14 302.28 8.33 .03 $301.20 31 106.05 2.71 .06 $59.81
15 .00 .00 .11 $0.00
16 83.59 2.09 .54 $1, 150.69
17 241.59 6.87 .01 $282.93
shipment and 2 distribution links) will rarely - if at all - be used in the pre-merger problem.
Furthermore, the projected weekly values of demand for red blood cells at hospitals R11
and R12 (corresponding to Organization 1) as well as hospitals R
2
1 and R
2
2 (corresponding to
Organization 2) are shown below:
OneBlood, Inc.: v∗11 = 385.03 units, v
∗
12 = 241.59 units, and
ITxM: v∗21 = 360.11 units, v
∗
22 = 106.05 units.
Note that for all four demand points, as we would expect, the value of the projected
demand falls between the lower and the upper bounds of their respective uniform distribution
ranges. In addition, for all four hospitals, this value is closer to the upper bound which
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suggests that the decision-makers in both organizations have assigned a much larger shortage
penalty as compared to the surplus penalties. It should be mentioned that adjusting the
values of these penalties can assist the blood banks with the crucial tradeoff between the
shortage of red blood cell units and the expiration of unused units at the hospitals (cf.
Masoumi (2013)).
4.2 Solution to The Post-Merger Problem in the Case Study
Once/if the merger process between the two organizations is completed, the supply chain
network topology for the post-merger problem would evolve to the one depicted in Figure 5.
As seen in the new topology, both organizations now operate under a unified management
denoted by supernode 0. Newly added links 32 and 33, connecting node 0 to nodes 1 and
2 are assumed to have a total cost of zero in that the proposed mathematical framework
represents the operations of the blood banks in the post-merger situation rather than during
the process of merger. Furthermore, links 34 through 43 are added to reflect the fact that
each of the organizations now has the ability to ship the collected units of blood to the blood
centers of the other organization (for testing and processing, and storage) should it make
sense demand-wise and cost-wise. Similarly, under the new situation, the hospitals now
have an added flexibility to enjoy their demand being satisfied by the storage/distribution
centers of the other organization via links 44 through 51, if need be. Adding the new links to
the network topology quadruples the number of potential paths (from 20 in the pre-merger
problem to 80 in the post-merger problem).
Data corresponding to the multipliers, the capacities, and the cost functions of the new
links are displayed in Table 5 where we assume that the respective data regarding the pre-
existing links remain the same as in Tables 2 and 3.
Similar to the pre-merger problem, the aforementioned algorithm was applied to the above
post-merger problem using Matlab. The optimal values of the link flows, the weekly frequen-
cies of the activities, the Lagrange multipliers as well as the incurred values at optimality of
32
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Figure 5: Supply Chain Network Topology for the Post-Merger Problem in the Case Study
the total operational and discarding cost functions for the newly merged organization can
be seen in Table 6.
Comparing the optimal link flows of the blood organizations in the pre-merger problem
with those of the newly-merged organization reveals the following results. For both organiza-
tions, the majority of links in the post-merger problem have maintained similar flows to the
pre-merger problem. However, a few links (mostly of distribution type, including Links 16,
17, and 30) demonstrate some notable changes in the optimal weekly amount of blood to be
distributed to their respective hospitals. On the other hand, apart from the non-operational
Links 32 and 33 (representing the merger), only 3 out of the 18 newly added links play a
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Table 5: Throughput Multipliers, Weekly Capacities, Total Operational Cost and Total Discarding Cost
Functions for the New Links (32-51) in the Post-Merger Problem
Link a αa u¯a cˆa(fa, γa) zˆa(fa)
32 1.00 n/a 0 0
33 1.00 n/a 0 0
34 .99 30 .4(f34)
2 + 1f34 + 9(γ34)
2 + 4γ34 .75f34
35 .98 30 .15(f35)
2 + 1.4f35 + 10(γ35)
2 + 5γ35 .75f35
36 .99 30 .5(f36)
2 + 2f36 + 8(γ36)
2 + 7γ36 .9f36
37 .98 30 .25(f37)
2 + 1f37 + 12(γ37)
2 + 6.5γ37 .8f37
38 .98 30 .3(f38)
2 + 1.5f38 + 9(γ38)
2 + 4γ38 .75f38
39 .99 30 .55(f39)
2 + 2f39 + 10(γ39)
2 + 4.5γ39 .8f39
40 .99 25 .17(f40)
2 + 1.5f40 + 7(γ40)
2 + 6γ40 .75f40
41 1.00 25 .15(f41)
2 + 2f41 + 7.5(γ41)
2 + 4γ41 .6f41
42 .99 25 .2(f42)
2 + 2f42 + 6(γ42)
2 + 6γ42 .55f42
43 .98 25 .25(f43)
2 + 2.5f43 + 8(γ43)
2 + 6γ43 .7f43
44 .99 35 .15(f44)
2 + 3f44 + 4.5(γ44)
2 + 6γ44 .55f44
45 1.00 35 .17(f45)
2 + 3f45 + 7(γ45)
2 + 5γ45 .6f45
46 1.00 35 .18(f46)
2 + 2.5f46 + 5(γ46)
2 + 4.5γ46 .65f46
47 .99 35 .16(f47)
2 + 3.5f47 + 4(γ47)
2 + 7γ47 .65f47
48 1.00 32 .35(f48)
2 + 3f48 + 2.5(γ48)
2 + 5γ48 .55f48
49 .99 32 .38(f49)
2 + 4f49 + 2(γ49)
2 + 6γ49 .65f49
50 .98 32 .4(f50)
2 + 1.8f50 + 3(γ50)
2 + 5.5γ50 .5f50
51 1.00 32 .35(f51)
2 + 1.5f51 + 2.5(γ51)
2 + 7γ51 .55f51
relatively significant role in the post-merger problem. Interestingly, all three are distribu-
tion links, representing potential shipments of blood between the following origin-destination
pairs:
• Link 46: from the storage facility in Tampa to the large-size hospital in Chicago with
a weekly amount of 49.11 units;
• Link 50: from the storage facility in Pittsburgh to the large-size hospital in Florida
with a weekly amount of 30.25 units; and
• Link 51: from the storage facility in Pittsburgh to the medium-size hospital in Florida
with a weekly amount of 18.73 units.
34
Table 6: Optimal Values of the Weekly Link Flows, Weekly Frequencies of Activities, Lagrange Multi-
pliers, as well as the Incurred Values of the Total Operational and Discarding Cost Functions for the New
Organization in the Post-Merger Problem
Link a f ∗a γ
∗
a η
∗
a cˆa(f
∗
a , γ
∗
a) Link a f
∗
a γ
∗
a η
∗
a cˆa(f
∗
a , γ
∗
a)
+zˆa(f
∗
a ) +zˆa(f
∗
a )
1 208.21 1.04 .01 $5, 844.91 27 190.68 .09 .00 $2, 391.24
2 182.24 .81 .01 $5, 164.86 28 275.86 9.10 .04 $201.94
3 300.78 1.34 .01 $9, 334.38 29 .00 .15 .11 $0.00
4 191.06 5.44 .00 $393.00 30 35.78 1.02 .29 $591.98
5 4.74 .19 .26 $16.33 31 105.91 2.70 .03 $59.71
6 125.61 3.07 .03 $188.13 32 691.23 n/a .00 $0.00
7 49.21 1.64 .11 $163.17 33 491.01 n/a .00 $0.00
8 .00 .00 .08 $0.00 34 6.16 .21 .26 $27.16
9 297.77 7.50 .09 $271.85 35 .00 .00 .17 $0.00
10 315.42 .17 .00 $55, 602.90 36 3.77 .13 .30 $19.02
11 352.62 .22 .00 $57, 080.43 37 .00 .00 .22 $0.00
12 302.80 .15 .00 $6, 812.00 38 .00 .00 .13 $0.00
13 331.46 .21 .00 $6, 956.56 39 .00 .00 .15 $0.00
14 299.78 8.39 .03 $299.18 40 .00 .00 .24 $0.00
15 .00 .00 .09 $0.00 41 .00 .00 .16 $0.00
16 56.24 1.41 .41 $585.76 42 .00 .00 .24 $0.00
17 222.79 6.36 .00 $260.96 43 .96 .04 .26 $3.54
18 275.74 1.06 .02 $8, 613.85 44 .00 .00 .17 $0.00
19 215.27 .92 .00 $6, 218.84 45 .00 .00 .13 $0.00
20 270.22 10.81 .59 $371.87 46 49.11 1.40 .53 $605.07
21 .00 .00 .11 $0.00 47 .00 .00 .18 $0.00
22 13.53 .39 .25 $51.10 48 .00 .00 .16 $0.00
23 198.62 5.73 .02 $176.08 49 .00 .00 .17 $0.00
24 293.32 .13 .00 $52, 119.02 50 30.25 .95 .35 $443.56
25 198.62 .10 .00 $33, 970.34 51 18.73 .59 .31 $166.11
26 278.65 .11 .00 $4, 160.94
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This shows that, under normal demand scenarios, it makes sense for the newly-merged
organization to allow merely between 10-20% of the demand of selected under-contract hos-
pitals to be satisfied via a blood center located in the further location (belonging to the
other organization in the pre-merger problem). This result suggests that satisfaction of the
remaining hospital demand via the further blood center can not be economically justified
due to a significantly higher transportation cost (This will be further discussed in Section
4.4). In addition, the fact that Links 34 through 43 (connecting the collection sites of one
organization to the blood centers of the other organization) have negligible flows suggests
that two merging blood centers geographically located far apart will not benefit from the
possibility of having their collected blood processed and stored in the other blood center.
Furthermore, the projected weekly values of demand for red blood cells at the 4 hospitals in
the post-merger problem remain more-or-less unchanged:
v∗11 = 385.10 units, v
∗
12 = 241.52 units, v
∗
21 = 360.40 units, v
∗
22 = 105.91 units.
It should be noted here that the above results; specifically, the reported percentages of
demand to be satisfied by the other merging organization, to some extent depend on the
choice of the shortage and surplus penalties by the blood organization(s) in addition to the
parameters of the merger case (including but not limited to the operational cost functions
as well as the probability distribution of the demands). Nevertheless, the overall conclusion
can be generalized to a vast majority of mergers in the blood banking industry due to the
high cost of storage and transportation of this highly perishable product over long distances.
In the next section, we will analyze the synergy of a merger between two blood banks in
response to an unexpected demand surge such as a natural disaster.
4.3 Investigation of the Impact of a Surge in Demand on a Merger
Terrorist attacks, natural disasters, as well as pandemics can result in a surge in demand
for blood (cf. Mulcahy et al. (2016)). In this section, we investigate potential efficiencies
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that can be garnered in the case of such an event, realizing also that in the case of climate
change and even urbanization as well as increased global mobility, disaster preparedness, in
which a sustainable blood supply plays a key role, is of critical importance.
In this section, we use the same merger case described earlier in this section to compare the
resiliency of blood banks in the pre- and post-merger problems during the response phase of
a disaster, which leads to a surge in demand. Assume a relatively large-scale natural disaster
has hit parts of Florida, resulting in an abrupt surge in the demand for red blood cells in the
two aforementioned Floridian hospitals immediately after the occurrence of the disaster. We
assume the demand at R11 and R
1
2 during that week follows a continuous uniform distribution
on the intervals [2000,4000] and [1500,2500], respectively; i.e., an increase by a factor of 10 as
compared to the base scenario. The demand at the other two hospitals (located in Chicago
and Pittsburgh) remains unchanged; i.e., [220,370] for R21 and [80,110] for R
2
2. Furthermore,
we assume the structure of the two blood organizations as well as all parameters of the
pre- and post-merger problems (including the operational and discarding cost functions, arc
multipliers, capacities on links, and unit shortage and surplus penalties) stay the same as
their respective values.
We used the same computational framework to calculate the optimal solution (link flows,
frequencies of activities as well as Lagrange multipliers) for the pre-merger problem and the
post-merger one. Here, we report the highlights of the results for the demand surge case.
4.3.1 Pre-Merger Problem Under a Demand Surge
The projected values of demand for red blood cells at the 4 hospitals during the week
following the disaster are as follows. For OneBlood, Inc., we have: v∗11 = 2, 951.65 and
v∗12 = 1, 919.88. For ITxM, we have: v
∗
21 = 360.11, and v
∗
22 = 106.55. As expected, the
projected demand for the hospitals in Florida has significantly risen while the other two
stayed unchanged. The values of the projected demand for R11 and R
1
2 still fall between the
lower and upper bounds of the uniform distribution, although they are a bit closer to the
37
lower bound as a result of the choice of the unit shortage penalties by the decision-maker
given that the blood bank is utilizing the same network structure to respond to the abrupt
demand surge.
The optimal link flows and frequencies on links corresponding to Organization 1 (OneBlood)
have largely increased to be able to respond to the demand surge in the hospitals. The other
organization experiences no changes, not surprisingly.
4.3.2 Post-Merger Problem Under a Demand Surge
We now have the following projected values of demand for red blood cells during the week
of the disaster: v∗11 = 3, 239.64, v
∗
12 = 2, 080.32, v
∗
21 = 328.26, and v
∗
22 = 91.93. As seen here,
values of the projected demand for the hospitals located in the disaster-impacted region have
now shifted closer to the upper bound of their uniform distributions. Interestingly, the other
two hospitals (located over a thousand miles away from the region) have suffered drops of
8.8% and 13.7% in their projected demand values. This is because the new organization
now minimizes the overall objective value of the entire network which results in the shortage
being distributed across the network.
Several links across the supply chain network experience increased flows and frequencies
in the optimal solution. For example, the optimal flow on blood collection Links 18 and
19 (located in Chicago and Pittsburgh) have increased to 1,378.23 and 1,115.24 units; i.e.,
increases of 381.28% and 419.97% as compared to the pre-merger problem, respectively.
4.4 Discussion: Synergy of the Mergers
We have summarized the comparison of the two blood banks in the pre- and post-merger
problems under status quo versus the increased demand scenario from a cost perspective in
Table 7.
As seen in Table 7, under status quo demand scenario, the total weekly value of objective
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Table 7: Comparison of the Optimal Values of the Weekly Projected Demand, Total Objective Value,
Expected Total Shortage and Surplus Costs under Status Quo and Disaster Scenarios corresponding to Pre-
Merger and Post-Merger Problems, as well as the Total Cost Efficiency (Synergy), Shortage and Surplus
Penalty Measures
Status Quo Scenario Disaster Scenario
Pre-Merger Post- Pre-Merger Post-
OneBlood, Inc. ITxM Merger OneBlood, Inc. ITxM Merger
Projected v
∗
11 385.03 – 385.10 2, 951.65 – 3, 239.64
v∗12 241.59 – 241.52 1, 919.88 – 2, 080.32
Demand v
∗
21 – 360.11 360.40 – 360.11 328.26
v∗22 – 106.05 105.91 – 106.55 91.93
Total Objective
Value
$161, 753.22 $119, 078.72 $278, 957.84 $11, 666, 944.68 $119, 079.06 $8, 966, 685.81
Expected Total
Shortage Cost
$6, 044.32 $3, 570.41 $9, 528.83 $2, 932, 952.43 $3, 570.03 $1, 606, 741.21
Expected Total
Surplus Cost
$6, 796.02 $3, 465.61 $10, 263.21 $16, 609.31 $3, 465.64 $31, 052.66
ET C 0.67% 23.92%
S− 0.67% 45.28%
S+ −0.02% −54.68%
function (5) including the total shortage and surplus penalties for Organizations 1 and 2 (i.e.,
OneBlood, Inc., and ITxM, as shown in Figure 4) in the pre-merger problem are $161,753.22,
and $119,078.72, respectively.
In the post-merger problem, the total weekly value of objective function (13) is $278,957.84.
Utilizing the introduced total cost synergy measure in (14) while taking into account this
objective value along with the ones reported above for Organizations 1 and 2 yields a paltry
ET C value of 0.67% for the pending merger between the two blood banks. In addition, the
values of the supply shortage synergy measure, S−, and the surplus synergy measure, S+,
are 0.67% and -0.02%, respectively (see equations (15) and (16)).
Under the demand surge scenario, in the pre-merger problem, the total objective value
of (5), corresponding to OneBlood, Inc., has risen to $11,666,944.68 including $8.7M in
operational costs as well as a $2.9M shortage penalty. The total objective value of ITxM
remains unchanged.
39
In the post-merger problem, the total objective value of the new organization, (13), is
$8,966,685.81 resulting in a remarkable 23.92% total cost synergy (ET C) during the time of
disaster (see (14)). More importantly, the supply shortage synergy, S−, see (15), reaches
a significant 45.28%, contributing to the resiliency of the organization during the disaster
as a result of the merger. In contrast, the surplus synergy measure, S+, see (16), shows a
major decrease of -54.68%. It should be noted that the surplus penalty is of least importance
during the response phase of a disaster. In addition, the dollar value of the surplus penalty
in the post-merger problem is merely $31,052.66 as compared to the $1,606,741.21 shortage
penalty justifying the relative importance of the shortage when compared to the surplus
penalty under the disaster-related demand surge scenario.
Comparing the values in the last three rows of Table 7 corresponding to status quo and
the demand surge, specifically the total cost synergy measure, ET C, as well as the expected
total shortage synergy measure, S−, reveals the following conclusion. When the two merging
blood banks are geographically distant, the synergy gained from the merger is not significant
under normal demand situations. In contrast, under a demand surge scenario, the merged
organization will experience a significant synergy, both in terms of the total operational cost
as well as the expected shortage penalty despite the distance between the blood banks. The
two aforementioned outcomes (improved operational efficiency and enhanced stability of the
blood supply) are the major motives for blood organizations to merge. Thus, blood banks
should take into careful consideration the intensity of irregular demand scenarios, in addition
to other operational and organizational factors, when facing the crucial decision of a merger,
acquisition, or any other form of alliance.
5. Conclusions
The blood banking industry, critical to healthcare, is at a crossroads in the United States,
with medical and technological advances, as well as economic pressures, resulting in a down-
ward demand trend for blood products. As a consequence, the past decade has seen a
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doubling in the number of mergers and acquisitions in this sector, in comparison to the
decade prior, with a big driver being cost reduction.
In this paper, we develop a methodological framework that allows for the quantifiable
assessment of a merger or acquisition concerning blood banks. Blood is a unique product in
that it cannot be produced but must be donated and, at the same time, it is a perishable
product with red blood cells having a lifetime of only 42 days. In particular, we construct
network optimization pre-merger and post-merger models reflecting blood supply chains of
different blood banks, which have the following features:
1. The models capture perishability of blood through link multipliers, which reflect the
throughput on a link, be it a collection, processing and testing, storage, or distribution link,
along with the capacity on the link (over a time horizon, such as a week).
2. The models, when solved, yield the cost-minimizing blood flows on paths and links in
the network(s), along with the frequencies of the link activities, and the Lagrange multipliers
associated with the capacity constraints.
3. Uncertainty on the demand side is captured along with discarding costs associated
with waste on the links, and costs associated with expected shortages or surpluses at the
demand points.
4. A total cost efficiency measure is introduced, which quantifies the potential synergy
associated with the merger or acquisition, along with measures capturing the expected supply
shortage and surplus.
5. A case study, focusing on a real-world pending merger is then presented, under two
different scenarios - one considering the status quo and the other - a time of a disaster.
The proposed methodological framework can handle the assessment of a pending merger
or acquisition of two or more blood bank organizations and can serve as a valuable tool for
such organizations in these uncertain and volatile times for the industry.
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Nevertheless, in this paper, we focused on vertically integrated blood service organiza-
tions. We did not consider a decentralized blood supply chain network, involving different
blood collection organizations and individual hospitals. Moreover, we did not consider uncer-
tainties on the supply side, as well as possible disruptions in blood supply chain operations.
Finally, it would also be interesting to capture a combination of for-profit as well as non-profit
actors in blood supply chains.
In addition, in future research, the time component can be explicitly captured in an
extension of the model(s). Furthermore, the time consumption associated with each blood
supply chain activity may depend on not only the amount of blood products but also on the
activity frequency.
Although there are directions for future research, our framework fills a gap in the literature
since it provides a methodology to assess mergers and acquisitions in a healthcare industry
of a unique, highly perishable product, that of blood.
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Appendix
Proof of Theorem 1:
Let TC0i denote that part of the objective function (5) corresponding to blood service orga-
nization i; i = 1, . . . , I. Since the functions in (5) are convex and continuously differentiable
and the feasible set K is closed and convex, based on the classical theory of variational
inequalities (see Kinderlehrer and Stampacchia (1980) and Nagurney (1999)), we know that
the optimal solution to (5) coincides with the solution to the following variational inequality:
determine (x∗, γ∗, η∗) ∈ K, such that:
I∑
i=1
niR∑
k=1
∑
p∈P0
Ri
k
[
∂TC0i
∂xp
+
∑
a∈Li
η∗aαap
]
× [xp − x∗p] +
I∑
i=1
∑
a∈Li
[
∂TC0i
∂γa
− u¯aη∗a
]
× [γa − γ∗a]
+
I∑
i=1
∑
a∈Li
u¯aγ∗a − ∑
q∈P0
x∗qαaq
× [ηa − η∗a] ≥ 0, ∀(x, γ, η) ∈ K. (A1)
For each path p; p ∈ P0
Rik
, the partial derivative of the objective function with respect to the
flow on that path is calculated as follows:
∂TC0i
∂xp
=
∂[
∑
a∈Li cˆa(fa, γa) +
∑
a∈Li zˆa(fa) +
∑niR
k=1
(
λ−ikE(∆
−
ik) + λ
+
ikE(∆
+
ik)
)
]
∂xp
=
∑
a∈Li
∂cˆa(fa, γa)
∂xp
+
∑
a∈Li
zˆa(fa)
∂xp
+
niR∑
k=1
λ−ik
∂E(∆−ik)
∂xp
+
niR∑
k=1
λ+ik
E(∆+ik)
∂xp
=
∑
a∈Li
∂cˆa(fa, γa)
∂fa
∂fa
∂xp
+
∑
a∈Li
zˆa(fa)
∂fa
∂fa
∂xp
+
niR∑
k=1
λ−ik
∂E(∆−ik)
∂vik
∂vik
∂xp
+
niR∑
k=1
λ+ik
E(∆+ik)
∂vik
∂vik
∂xp
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=
∑
a∈Li
∂cˆa(fa, γa)
∂fa
αap +
∑
a∈Li
zˆa(fa)
∂fa
αap +
niR∑
k=1
λ−ik
∂E(∆−ik)
∂vik
µp +
niR∑
k=1
λ+ik
E(∆+ik)
∂vik
µp.
(A2)
Note that following Leibniz’s integral rule, we have
∂E(∆−ik)
∂vik
= Pik(vik)− 1 = Pik
 ∑
q∈P0
Ri
k
xqµq
− 1, i = 1, . . . , I; k = 1, . . . , niR, (A3a)
∂E(∆+ik)
∂vik
= Pik(vik) = Pik
 ∑
q∈P0
Ri
k
xqµq
 , i = 1, . . . , I; k = 1, . . . , niR. (A3b)
Similarly, for each link a; a ∈ Li, the partial derivative of the objective function with respect
to the frequency on that link is:
∂TC0i
∂γa
=
∂[
∑
a∈Li cˆa(fa, γa) +
∑
a∈Li zˆa(fa) +
∑niR
k=1
(
λ−ikE(∆
−
ik) + λ
+
ikE(∆
+
ik)
)
]
∂γa
=
∑
a∈Li
∂cˆa(fa, γa)
∂γa
+
∑
a∈Li
zˆa(fa)
∂γa
+
niR∑
k=1
λ−ik
∂E(∆−ik)
∂γa
+
niR∑
k=1
λ+ik
E(∆+ik)
∂γa
=
∑
a∈Li
∂cˆa(fa, γa)
∂γa
. (A4)
By making use of the definitions in (7a)–(7c) and the results in (A3a) and (A3b), varia-
tional inequality (6) is immediate. In addition, the equivalence between variational inequal-
ities (6) and (8) can be proved with (1)–(3). 
Explicit Formulae for the Euler Method Applied to Blood Supply Chain Network
Variational Inequality (6)
We now present a framework for the computation of the optimal solutions to the pre-
and post-merger blood banking problems. The below explicit formulae are the realization of
the Euler method, which is based on the general iterative scheme introduced by Dupuis and
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Nagurney (1993), for our model and iteratively yield the solution to the pre-merger blood
banking problem governed by variational inequality (6) (see also (8)).
Specifically, the closed form expression for the path flow on path p ∈ P0
Rik
; i = 1, . . . , I;
k = 1, . . . , niR, at iteration τ + 1 is:
xτ+1p =max{0, xτp + aτ
λ−ikµp
1− Pik
 ∑
q∈P0
Ri
k
xτqµq

− λ+ikµpPik
 ∑
q∈P0
Ri
k
xτqµq

−∂Cˆp(x
τ , γτ )
∂xp
− ∂Zˆp(x
τ )
∂xp
−
∑
a∈Li
ητaαap
]
}. (A5)
The closed form expression for the activity frequency γa; a ∈ Li; i = 1, . . . , I, is:
γτ+1a = max{0, γτa + aτ
[
u¯aη
τ
a −
∂Cˆp(x
τ , γτ )
∂γa
]
}, (A6)
with the Lagrange multipliers being computed for a ∈ L0 according to:
ητ+1a = max{0, ητa + aτ
∑
q∈P0
xτqαaq − u¯aγτa
}. (A7)
As shown in Dupuis and Nagurney (1993), as well as in Nagurney and Zhang (1996),
convergence of the iterative scheme requires that the sequence {aτ} satisfies:
∑∞
τ=0 aτ =∞,
aτ > 0, aτ → 0, as τ →∞. The aforementioned references contain additional conditions for
convergence as well as other network applications.
Note that the explicit formulae for the post-merger model are akin to the respective
expressions (A5) – (A7) where a ∈ L1, p ∈ P1
nik
, for i = 1, . . . , I, and k = 1, . . . , niR.
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